Medical supplies market - ophthalmology supplies risk analysis.

Ophthalmology is a discipline that occurs in the visual system, including the eyeball and the tissue associated with it.
high-value medical supplies for the treatment of ophthalmology refers to high-value medical supplies for the treatment of ophthalmological diseases, divided according to the location of product use, can be divided into in-eye supplies, eye watch supplies and other supplies.
products mainly include artificial crystals, artificial corneas, glazing implants, surgical glass fillers, viscous elastomers, artificial eyeballs, artificial bone and so on.
ophthalmology medical device industry is one of the fastest growing areas of China's medical industry, according to the Institute of Medical Research data, in 2018 China's eye high-value medical supplies market size of about 7.6 billion yuan, an increase of 16.92 percent year-on-year, the largest market is for cataract treatment artificial crystals.
artificial crystals used to treat cataracts, is the world's largest use of artificial organs and implantable medical device products.
surgical implantation of artificial lenses to replace turbid natural crystals is the only effective means of treating cataracts.
With the intensification of the aging of the Chinese mouth and the increase in the frequency of unreasonable eye use, ophthalmological diseases continue to grow, according to statistics from the Ophthalmology Branch of the Chinese Medical Association, the incidence of cataracts in China's 60-89-year-old population is about 80%, and the incidence rate of people over 90 years of age has reached more than 90%.
but China's ophthalmology product market penetration rate is relatively low, in 2018 China's million people cataract surgery rate (CSR) is only 2600, compared to Europe and the United States and Japan CSR has reached 9000 there is still a big gap.
with the improvement of economic level and people's health awareness, the market prospect of high-value ophthalmology supplies is broad.
companies that have developed rapidly in artificial crystals are Aibo Medical, Coronary Bio and Bohai Biotech.
Aibo Medical is China's first high-end recrystalline artificial crystal manufacturers, is also one of the main collapsible artificial crystal manufacturers, with artificial crystal core technology and complete independent intellectual property rights, breaking the monopoly of international manufacturers in high-end artificial crystal technology and market, 2019 operating income of 195 million yuan; Through the introduction of U.S. Aerry artificial crystals and Ai Shuming artificial crystals, 2019 artificial crystals to achieve operating income of 144 million yuan, Bohai Biotech in high-value medical supplies mainly produce and sell artificial crystals and optical materials, its investment in research and development is high, in 2019 operating income of 1.6 billion yuan, research and development expenditure of 116 million yuan.
1. High technical threshold, foreign enterprises monopolize the market ophthalmology high-value consumables on the materials and technology of the degree of refinement requirements, the current global ophthalmology supplies market is mainly Ercon (Novarco), Clear, Eye Health (Abbott), Dr. Len and ZEISS-led international enterprises occupied.
China's ophthalmology market started late, foreign companies monopolized the market, Erkang, Eye Health and Dr. Lun three occupy more than 80% of the market share.
2. From the second half of 2018, the growth rate of low-end cataract surgery slowed down gradually due to the adjustment of health insurance policy integration and the optimization structure of health insurance.
With cataract surgery increasingly changing from re-opening surgery to recrystalline surgery, the use of medium- and high-end artificial crystals, which can improve visual quality, is increasing, but the out-of-payment ratio is higher than the medical insurance limit.
3. The impact of technological progress cataract ultrasound emulsification combined with soft foldable artificial crystal implantation surgery has become a mainstream technology, hard PMMA artificial crystal surgery is highly traumatic, poor vision recovery after surgery, gradually withdraw from the stage.
changes in demand have promoted the continuous progress of artificial lens materials, optics and structural design, and various new recessive artificial lenses have emerged, such as as-sporad, toric, multi-focus and adjustable.
For example, hydrophobic acrylic crystals can be folded into the eye through 2.2mm surgical micro-incusses, good stability, post-cataract (PCO), calcification, low rate of protein deposition; Photo-artificial crystal material can reduce the radiation damage of harmful blue light radiation to the retina of human eye, and the modified artificial crystal material on the surface of heparin can improve the biological compatibness of artificial crystalline body, reduce postoperative inflammatory response, cell and pigment deposition.
.